Immunotherapeutics have transformed cancer outcomes. It is crucial that response patterns seen with them are assessed ...

IO Biotech (IOBT) announced the publication of results from a preclinical study of its second immune-modulatory therapeutic cancer vaccine ...

A set of 5844 free MIT-licensed high-quality SVG icons for you to use in your web projects. Each icon is designed on a 24x24 grid and a 2px stroke. If you load an icon as an image, you can modify its ...

Stuart Beaton, who was diagnosed with lung cancer, says in a lawsuit that he was forced to work in a building contaminated with asbestos ...

What Happened and How He’s Recovering NBA legend Dwyane Wade recently faced a personal health scare when he was diagnosed with kidney cancer, leading to a major surgery in which 40% of his kidney was ...

OSE Immunotherapeutics and Scienta Lab Establish Strategic Partnership to Leverage Artificial Intelligence in Precision ImmunotherapyNantes and ...

Several factors, including histopathologic subtypes of liver metastases, tumor-infiltrating lymphocyte (TIL) enrichment, and molecular subtypes, may help guide the identification of candidates for ...

Guillain-Barre Syndrome is a rare immunological nerve disorder that causes sudden numbness and muscle weakness.

Monash University scientists have identified an immune system power play behind serious bee venom allergy, which lands twice as many Australians in hospital emergency departments each year as snake or ...

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs ...

1Combination Strategies for Translational Immunotherapy, Immunology and Immunotherapy Program, Centro de Investigación Médica Aplicada (CIMA) Universidad de Navarra, Pamplona, Spain. 2Department of ...

1Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany. 2Medical Faculty, University Duisburg-Essen, Essen, Germany. 3National Center of Tumor Diseases ...